Thrilled to share a remarkable achievement by Venus Remedies, as it proudly expands its global footprint in the field of oncology. With a recent contract win in Ukraine, Venus Remedies has taken a significant step towards combating cancer in a nation ravaged by war. This momentous occasion signifies our commitment

Venus Pharma GmbH, the German subsidiary of Venus Remedies Limited, has recently received a Marketing Authorization (MA) certificate from the UK Medicines and Healthcare products Regulatory Agency (MHRA) for its chemotherapy drug, Cisplatin. The company has been granted the license to market this drug in three different strengths: 10mg-10ml, 50mg-50ml,

Venus Remedies Limited has been granted a representative office license in Vietnam, expanding our reach and allowing us to provide even more comprehensive healthcare solutions to patients in the region. Venus Remedies Limited is a leading pharmaceutical company committed to providing innovative and high-quality healthcare solutions to people worldwide. With

The Barbados Drug Service has approved Venus Remedies Limited products for use in the country, marking a significant step forward in our commitment to providing innovative and high-quality healthcare solutions worldwide. The Barbados Drug Service is a government agency responsible for regulating and providing access to essential drugs and healthcare

Venus recently received Good Manufacturing Practices (GMP) Certification from Saudi Arabia for all its production facilities at its Baddi, Himachal Pradesh unit, thus taking the organization's total global GMP certifications to 20. The Saudi Food and Drug Authority (SFDA) while granting this certification also renewed the approval for Cephalosporin and

Venus has been working on target-based drug delivery for cancer treatment and diagnostics. The company has recently received marketing authorizations for its cancer drugs from Uzbekistan and Palestine. It has received marketing approval for Carboplatin in Uzbekistan and Docetaxel and Irinotecan in Palestine. With over 800 marketing authorizations worldwide, this

Venus emerged as the first pharma company in the country to have received the prestigious Responsible Export Organisation (REO) Certification from the Confederation of Indian Industry (CII) following an elaborate screening and assessment process. The certification is an endorsement of the company’s export capabilities and manufacturing prowess. It will

Venus received the coveted Good Distribution Practices (GDP) Certification (WHO TRS 957 ANNEX-5) for quality services throughout the Supply Chain Cycle, i.e., from product manufacturing to delivery to end-consumer. SGS (Société Générale de Surveillance) is the world’s leading testing, inspection and certification company. SGS awarded this remarkable certification